499 related articles for article (PubMed ID: 9262371)
41. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR
J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944
[TBL] [Abstract][Full Text] [Related]
42. The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.
Marzella PL; Hill C; Keks N; Singh B; Copolov D
Biol Psychiatry; 1997 Oct; 42(8):648-54. PubMed ID: 9325557
[TBL] [Abstract][Full Text] [Related]
43. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
Johansson B; Georgiev V; Fredholm BB
Neuroscience; 1997 Oct; 80(4):1187-207. PubMed ID: 9284070
[TBL] [Abstract][Full Text] [Related]
44. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Baldessarini RJ
Neuroscience; 1998 Nov; 87(1):1-4. PubMed ID: 9722137
[TBL] [Abstract][Full Text] [Related]
45. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
[TBL] [Abstract][Full Text] [Related]
46. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
[TBL] [Abstract][Full Text] [Related]
47. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
48. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
49. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
Lillrank SM; Lipska BK; Weinberger DR; Fredholm BB; Fuxe K; Ferré S
Neurochem Int; 1999 Mar; 34(3):235-44. PubMed ID: 10355490
[TBL] [Abstract][Full Text] [Related]
50. Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
Seeman P; Van Tol HH
J Neurochem; 1995 Mar; 64(3):1413-5. PubMed ID: 7861175
[TBL] [Abstract][Full Text] [Related]
51. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
[TBL] [Abstract][Full Text] [Related]
52. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
[TBL] [Abstract][Full Text] [Related]
53. Autoradiographic localization of dopamine D2 receptors in the rat brain using the new agonist [3H]N-0437.
van der Weide J; Camps M; Horn AS; Palacios JM
Neurosci Lett; 1987 Dec; 83(3):259-63. PubMed ID: 2964569
[TBL] [Abstract][Full Text] [Related]
54. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
55. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
Wallace DR; Booze RM
J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
[TBL] [Abstract][Full Text] [Related]
56. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
Hall H; Sedvall G; Magnusson O; Kopp J; Halldin C; Farde L
Neuropsychopharmacology; 1994 Dec; 11(4):245-56. PubMed ID: 7531978
[TBL] [Abstract][Full Text] [Related]
57. Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study.
Minuzzi L; Cumming P
Neurochem Int; 2010; 56(6-7):747-52. PubMed ID: 20117160
[TBL] [Abstract][Full Text] [Related]
58. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
59. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
Dewar KM; Montreuil B; Grondin L; Reader TA
J Pharmacol Exp Ther; 1989 Aug; 250(2):696-706. PubMed ID: 2527300
[TBL] [Abstract][Full Text] [Related]
60. Characterization of [3H]clozapine binding sites in rat brain.
Kusumi I; Matsubara S; Takahashi Y; Ishikane T; Koyama T
J Neural Transm Gen Sect; 1995; 101(1-3):51-64. PubMed ID: 8695057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
